GGrantIndex
← Leaderboards

Johannes Czernin

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗
$5,995,082
Attributed
$10,435,382
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,435,382 · 9

By mechanism

R01$6,302,515 · 3
P01$1,728,204 · 1
P50$1,098,741 · 1
P30$943,506 · 3
R21$362,416 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsResearch PersonnelTumorPre-ClinicalPositron-Emission TomographyMolecular ImagingEngineeringImageMonitorIn VivoCancer PatientCancer TherapyResponseLeadRadiochemistryBaseCellsSignal TransductionT-LymphocytePharmaceutical PreparationsMass Spectrum AnalysisDesignCollaborationsMetabolism

Grant awards (29)

Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC$584,235
R01 · FY2025 · CA · contact PI
Cancer Molecular Imaging, Nanotechnology, and Theranostics (CMINT)$110,852
P30 · FY2025 · CA · contact PI
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC$567,087
R01 · FY2024 · CA · contact PI
Cancer Molecular Imaging, Nanotechnology and Theranostics$177,678
P30 · FY2024 · CA · contact PI
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC$528,393
R01 · FY2023 · CA · contact PI
Cancer Molecular Imaging, Nanotechnology and Theranostics$177,678
P30 · FY2023 · CA · contact PI
Cancer Molecular Imaging, Nanotechnology and Theranostics$177,678
P30 · FY2022 · CA · contact PI
Cancer Molecular Imaging, Nanotechnology and Theranostics$177,678
P30 · FY2021 · CA · contact PI
Cancer Molecular Imaging, Nanotechnology and Theranostics$121,942
P30 · FY2020 · CA · contact PI
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$585,018
R01 · FY2018 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$585,018
R01 · FY2017 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$585,018
R01 · FY2016 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$559,454
R01 · FY2015 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$518,617
R01 · FY2014 · CA
Biological Imaging Core$360,372
P01 · FY2014 · CA · contact PI
A New Theranostic System for PET Image Guided Radiotherapy of Cancer$194,941
R21 · FY2014 · CA · contact PI
Novel molecular imaging approaches to monitor gene and cell-based therapies$546,171
R01 · FY2013 · CA
Biological Imaging Core$323,386
P01 · FY2013 · CA · contact PI
A New Theranostic System for PET Image Guided Radiotherapy of Cancer$167,475
R21 · FY2013 · CA · contact PI
Novel molecular imaging approaches to monitor gene and cell-based therapies$593,141
R01 · FY2012 · CA
Biological Imaging Core$344,441
P01 · FY2012 · CA · contact PI
Novel molecular imaging approaches to monitor gene and cell-based therapies$650,363
R01 · FY2011 · CA
Biological Imaging Core$344,673
P01 · FY2011 · CA · contact PI
Biological Imaging Core$355,332
P01 · FY2010 · CA · contact PI
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase$257,338
P50 · FY2009 · CA · contact PI
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase$258,131
P50 · FY2008 · CA · contact PI
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase$258,182
P50 · FY2007 · CA · contact PI
Metabolic Phenotyping with PET to Monitor /Predict Respo$162,545
P50 · FY2006 · CA · contact PI
Metabolic Phenotyping with PET to Monitor /Predict Respo$162,545
P50 · FY2005 · CA